SRC and breast cancer: A recent study demonstrated that the Src inhibitor SKI-606 blocks the invasion of basal-type MDA-MB-231 breast cancer cells in vitro, as well as the spontaneous metastasis of MDA-MB-231 cells from the mammary fat pad of nude mice (Jallal et al, 2007).